A significant percentage of patients with RA and ANCA positivity were also diagnosed with AAV, with GPA being the most common subtype.

Relapse is common among patients with systemic polyarteritis nodosa, with mycophenolate performing similarly to cyclophosphamide.

Vasculitis is an autoimmune disorder that causes inflammation of the blood vessels. It can affect arteries, veins, and capillaries. This condition causes blood vessel walls to swell, which ...

An elderly patient who was initially suspected of having antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) was instead diagnosed with multiple myeloma, according to a case report ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial ...

The different vasculitis syndromes are classified by the size of blood vessel predominantly affected. The etiology of autoimmune disease anti-neutrophil cytoplasmic antibody (ANCA)-associated ...

A phase 1 study of ADI-001 for the treatment of lupus nephritis is now enrolling patients, and an ANCA-associated vasculitis trial is expected to begin enrollment in the second half of this year.

Detailed price information for Cartesian Therapeutics Inc (RNAC-Q) from The Globe and Mail including charting and trades.

Learn more about whether Alnylam Pharmaceuticals, Inc. or argenx SE is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Cutaneous vasculitis (CV) is a term used for inflammation ... Other clinical features include: The patient has the following antibodies: P-ANCA positive with perinuclear pattern (anti ...

(NASDAQ:ARGX – Free Report) had its price target increased by Guggenheim from $775.00 to $1,100.00 in a report released on Monday morning,Benzinga reports. They currently have a buy rating on the ...